RA

Rahul Acholiya

Active Director Director DIN 09248589
DIN 09248589 First appointment Jul 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Rahul Acholiya

Data last updated:

Rahul Acholiya is a Director at Bann Pharmaceuticals And Surgicals Private Limited (since 2021). The company operates in Trading.

DIN 09248589
Primary Designation Director
Industry Trading
First Appointment 21 Jul 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 20212021Active

Board colleagues of Rahul Acholiya

Directorship timeline

Open interactive timeline →
Bann Pharmaceuticals And Surgicals Private Limited
Premium access

Shareholding and investment profile for Rahul Acholiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rahul Acholiya

Rahul Acholiya currently holds 1 directorship: Bann Pharmaceuticals And Surgicals Private Limited (Director, since 21 Jul 2021).

Rahul Acholiya was first appointed on 21 Jul 2021 as Director at Bann Pharmaceuticals And Surgicals Private Limited.

The current boards of Rahul Acholiya's companies include Himanshu Chaturvedi (Bann Pharmaceuticals And Surgicals Private Limited), Madhu Bala Jain (Bann Pharmaceuticals And Surgicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available